comparemela.com


Graphic Online
BY: Kweku Zurek
30.5k
Shares
705
Countries relying on the COVAX scheme to vaccinate their citizens against the COVID-19 pandemic will have to make alternative arrangements after the Serum Institute of India (SII), the largest single supplier to the scheme said shipments would only resume at the end of this year.
The scheme was set up last year to try to ensure fair access to vaccines among rich and poor nations but the SII has made none of its planned shipments since exports were suspended in March as a result of India's COVID-19 health crisis.
More than 49 million vaccine doses have been delivered through COVAX so far but there were no shipments for March, April or May after a deadly second wave of infections in India.

Related Keywords

India ,Congo ,Ghana ,Adar Poonawalla ,Coalition For Epidemic Preparedness Innovations Cepi ,Serum Institute Of India ,Astrazeneca Plc ,Global Vaccine Alliance Gavi ,Serum Institute ,Global Vaccine Alliance ,Epidemic Preparedness Innovations ,Zeneca Plc ,Democratic Republic ,Serum Institute To Resume Vaccine Exports At The End Of 2021 ,இந்தியா ,காங்கோ ,கானா ,அடார் பூனாவல்ல ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,உலகளாவிய தடுப்பூசி கூட்டணி கவி ,சீரம் நிறுவனம் ,உலகளாவிய தடுப்பூசி கூட்டணி ,பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள் ,ஸெநெக ப்ல் ,ஜனநாயக குடியரசு ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.